Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2575881
Title:
ANTICORPS SPÉCIFIQUES ANTI-CD160 POUR UN TRAITEMENT DE TROUBLES OCULAIRES BASÉES SUR LA NÉOANGIOGENÈSE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
117285940
WO application number:
EP2011058777
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2575881
WO publication number:
WO2011147984
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
27/05/2011
Grant date:
14/09/2016
EP publication date:
10/04/2013
WO publication date:
01/12/2011
Claims translation received date:
Translation received date (EP publication B1):
13/12/2016
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
14/09/2016
EP B1 publication date:
14/09/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/05/2024
Expiration date (if granted and all annual fees paid):
27/05/2031
Applicant
1
Name:
INSERM - Institut National de la Santé et de la
Recherche Médicale
Legal Form:
From:
13/12/2016
Address:
101, rue de Tolbiac, 75013 Paris, France (FR)
To:
2
Name:
Elsalys Biotech
Legal Form:
From:
13/12/2016
Address:
321 Avenue Jean Jaures, 69007, Lyon, France (FR)
To:
3
Name:
INSERM - Institut National de la Santé et de la
Recherche Médicale
Legal Form:
From:
14/09/2016
Address:
101, rue de Tolbiac, 75013 Paris, France (FR)
To:
13/12/2016
4
Name:
Mablife
Legal Form:
From:
14/09/2016
Address:
Genopole Campus
1 5 Rue Henri Desbrueres, 91030 Evry, France (FR)
To:
13/12/2016
Agent
Name:
KIRKPATRICK
Legal Form:
From:
13/12/2016
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws
2
Bulletin heading:
CO
Journal edition number:
2016/12
Publication date:
16/09/2019
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
3
Bulletin heading:
VRV
Journal edition number:
2025/01
Publication date:
21/02/2025
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)